There was no significant difference between the HL and CD30-positive NHL groups for either parameter (Mann–Whitney U-Test: percentage of CD30+ cells p = 0.095; double positivity among CD30+ cells p = 0.408). This evidence concerns the gene TNFRSF8 and Hodgkins lymphoma.